122 related articles for article (PubMed ID: 10938185)
1. Does abnormal neuronal excitability exist in myotonic dystrophy? II. Effects of the antiarrhythmic drug hydroquinidine on apathy and hypersomnia.
Di Costanzo A; Mottola A; Toriello A; Di Iorio G; Tedeschi G; Bonavita V
Neurol Sci; 2000 Apr; 21(2):81-6. PubMed ID: 10938185
[TBL] [Abstract][Full Text] [Related]
2. Does abnormal neuronal excitability exist in myotonic dystrophy? I. Effects of the antiarrhythmic drug hydroquinidine on slow saccadic eye movements.
Di Costanzo A; Mottola A; Toriello A; Di Iorio G; Tedeschi G; Bonavita V
Neurol Sci; 2000 Apr; 21(2):73-80. PubMed ID: 10938184
[TBL] [Abstract][Full Text] [Related]
3. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
Orlikowski D; Chevret S; Quera-Salva MA; Laforêt P; Lofaso F; Verschueren A; Pouget J; Eymard B; Annane D
Clin Ther; 2009 Aug; 31(8):1765-73. PubMed ID: 19808135
[TBL] [Abstract][Full Text] [Related]
4. Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.
Annane D; Miller R; Barnes P
Cochrane Database Syst Rev; 2002; (4):CD003218. PubMed ID: 12519589
[TBL] [Abstract][Full Text] [Related]
5. Apathy and hypersomnia are common features of myotonic dystrophy.
Rubinsztein JS; Rubinsztein DC; Goodburn S; Holland AJ
J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):510-5. PubMed ID: 9576545
[TBL] [Abstract][Full Text] [Related]
6. [Comparative effects of cibenzoline and hydroquinidine in the prevention of auricular fibrillation. A randomized double-blind study].
Touboul P; Brembilla-Perrot B; Scheck F; Gabriel A; Lardoux H; Marchand X; Levy S
Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):525-31. PubMed ID: 8745663
[TBL] [Abstract][Full Text] [Related]
7. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
Talbot K; Stradling J; Crosby J; Hilton-Jones D
Neuromuscul Disord; 2003 Jun; 13(5):357-64. PubMed ID: 12798791
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of a 20-mg dose of methylphenidate for the treatment of daytime sleepiness in adult patients with myotonic dystrophy type 1: a 2-center, randomized, double-blind, placebo-controlled, 3-week crossover trial.
Puymirat J; Bouchard JP; Mathieu J
Clin Ther; 2012 May; 34(5):1103-11. PubMed ID: 22578232
[TBL] [Abstract][Full Text] [Related]
9. Alveolar hypoventilation and hyperosmnia in myotonic dystrophy.
Coccagna G; Mantovani M; Parchi C; Mironi F; Lugaresi E
J Neurol Neurosurg Psychiatry; 1975 Oct; 38(10):977-84. PubMed ID: 172608
[TBL] [Abstract][Full Text] [Related]
10. Relationships between heart rate variability and antiarrhythmic effects of hydroquinidine.
Brembilla-Perrot B; Jacquemin L; Beurrier D
Cardiovasc Drugs Ther; 1997 Jul; 11(3):493-8. PubMed ID: 9310279
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of the efficacy of 2 delayed-action preparations of hydroquinidine and quinidine in the prevention of pacing induced ventricular tachycardia].
Lévy S; Moyal C; Dolla E; Cointe R; Bru P; Lauribe P; Paganelli F; Chanu P; Gérard R
Arch Mal Coeur Vaiss; 1993 Sep; 86(9):1359-63. PubMed ID: 8129554
[TBL] [Abstract][Full Text] [Related]
12. Selegiline in the treatment of hypersomnolence in myotonic dystrophy: a pilot study.
Antonini G; Morino S; Fiorelli M; Fiorini M; Giubilei F
J Neurol Sci; 1997 Apr; 147(2):167-9. PubMed ID: 9106123
[TBL] [Abstract][Full Text] [Related]
13. Myotonic dystrophy type 1, daytime sleepiness and REM sleep dysregulation.
Dauvilliers YA; Laberge L
Sleep Med Rev; 2012 Dec; 16(6):539-45. PubMed ID: 22465566
[TBL] [Abstract][Full Text] [Related]
14. Loss of serotonin-containing neurons in the raphe of patients with myotonic dystrophy: a quantitative immunohistochemical study and relation to hypersomnia.
Ono S; Takahashi K; Jinnai K; Kanda F; Fukuoka Y; Kurisaki H; Mitake S; Inagaki T; Yamano T; Nagao K
Neurology; 1998 Feb; 50(2):535-8. PubMed ID: 9484393
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the efficacy of propafenone and hydroquinidine in stabilized extrasystolic ventricular arrhythmia by means of dynamic electrocardiographic Holter monitoring].
Rizzon P; De Toma L; Mangini SG; Lagioia R; Scrutinio D; Accettura D; De Nicolò M
G Ital Cardiol; 1984 May; 14(5):345-51. PubMed ID: 6205924
[TBL] [Abstract][Full Text] [Related]
16. [Antiarrhythmic efficacy and tolerance of slow-release mexiletine in comparison with hydroquinidine retard].
Fazio S; Villari B; Petitto M; Santomauro M; Iacono C; Celentano A; de Divitiis O
Minerva Cardioangiol; 1987 Nov; 35(11):631-6. PubMed ID: 3444537
[No Abstract] [Full Text] [Related]
17. Treatment of hypersomnolence in myotonic dystrophy with a CNS stimulant.
van der Meché FG; Boogaard JM; van den Berg B
Muscle Nerve; 1986 May; 9(4):341-4. PubMed ID: 3713739
[TBL] [Abstract][Full Text] [Related]
18. Impact of a 12-week Strength Training Program on Fatigue, Daytime Sleepiness, and Apathy in Men with Myotonic Dystrophy Type 1.
Gallais B; Roussel MP; Laberge L; Hébert LJ; Duchesne E
J Neuromuscul Dis; 2022; 9(5):629-639. PubMed ID: 35848033
[TBL] [Abstract][Full Text] [Related]
19. [Propafenone versus hydroquinidine in long-term pharmacological prophylaxis of atrial fibrillation].
Richiardi E; Gaita F; Greco C; Gaschino G; Comba Costa G; Rosettani E; Brusca A
Cardiologia; 1992 Feb; 37(2):123-7. PubMed ID: 1600529
[TBL] [Abstract][Full Text] [Related]
20. Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.
Logigian EL; Martens WB; Moxley RT; McDermott MP; Dilek N; Wiegner AW; Pearson AT; Barbieri CA; Annis CL; Thornton CA; Moxley RT
Neurology; 2010 May; 74(18):1441-8. PubMed ID: 20439846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
